Promptly Health, with the slogan "Real-world evidence for a better healthcare", is an emerging global provider of end-to-end Real-World Evidence solutions. Founded in 2018 and headquartered in Portugal, the company operates in 10 countries and is positioned in the Analytics, Big Data, Health Care, and Health insurance industries. The company, along with a selected network of Partners, generates new knowledge from harmonized datasets, augmented with the collection of longitudinal patient-reported data and patient-generated digital biomarkers. Its efforts aim to promote better healthcare at lower costs for thousands of new patients every day through the use of Real-World Evidence. Promptly Health received a Non Equity Assistance investment on 08 December 2022 from PharmStars. Promptly Health's innovative approach to leveraging real-world evidence for healthcare improvements, combined with its global reach and industry positioning, makes it an intriguing prospect for venture capital investment. The companyβs focus on generating actionable insights from patient data and its collaboration with industry partners present opportunities for growth and impact within the rapidly evolving healthcare and data analytics sectors. As an emerging player in an increasingly significant space, Promptly Health has the potential to attract attention and investment from venture capitalists seeking opportunities at the intersection of healthcare, data, and technology.
No recent news or press coverage available for Promptly Health.